257 related articles for article (PubMed ID: 20175912)
1. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review.
Dankbaar JW; Slooter AJ; Rinkel GJ; Schaaf IC
Crit Care; 2010; 14(1):R23. PubMed ID: 20175912
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
3. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.
Origitano TC; Wascher TM; Reichman OH; Anderson DE
Neurosurgery; 1990 Nov; 27(5):729-39; discussion 739-40. PubMed ID: 2259403
[TBL] [Abstract][Full Text] [Related]
4. Effect of HHH-Therapy on Regional CBF after Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT.
Engquist H; Rostami E; Ronne-Engström E; Nilsson P; Lewén A; Enblad P
Neurocrit Care; 2018 Apr; 28(2):143-151. PubMed ID: 28983856
[TBL] [Abstract][Full Text] [Related]
5. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
6. Temporal Dynamics of Cerebral Blood Flow During the Acute Course of Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT.
Engquist H; Rostami E; Enblad P
Neurocrit Care; 2019 Apr; 30(2):280-290. PubMed ID: 30790226
[TBL] [Abstract][Full Text] [Related]
7. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
8. CBF changes and cerebral energy metabolism during hypervolemia, hemodilution, and hypertension therapy in patients with poor-grade subarachnoid hemorrhage.
Engquist H; Lewén A; Hillered L; Ronne-Engström E; Nilsson P; Enblad P; Rostami E
J Neurosurg; 2020 Jan; 134(2):555-564. PubMed ID: 31923897
[TBL] [Abstract][Full Text] [Related]
9. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
10. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
Meyer R; Deem S; Yanez ND; Souter M; Lam A; Treggiari MM
Neurocrit Care; 2011 Feb; 14(1):24-36. PubMed ID: 20838932
[TBL] [Abstract][Full Text] [Related]
11. Effects of Induced Hypertension on Cerebral Perfusion in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
Gathier CS; Dankbaar JW; van der Jagt M; Verweij BH; Oldenbeuving AW; Rinkel GJ; van den Bergh WM; Slooter AJ;
Stroke; 2015 Nov; 46(11):3277-81. PubMed ID: 26443829
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage.
Treggiari MM; Walder B; Suter PM; Romand JA
J Neurosurg; 2003 May; 98(5):978-84. PubMed ID: 12744357
[TBL] [Abstract][Full Text] [Related]
13. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study.
Murphy A; de Oliveira Manoel AL; Macdonald RL; Baker A; Lee TY; Marotta T; Montanera W; Aviv R; Bharatha A
Neurocrit Care; 2017 Aug; 27(1):3-10. PubMed ID: 28244000
[TBL] [Abstract][Full Text] [Related]
15. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage.
Dhar R; Scalfani MT; Zazulia AR; Videen TO; Derdeyn CP; Diringer MN
J Neurosurg; 2012 Mar; 116(3):648-56. PubMed ID: 22098203
[TBL] [Abstract][Full Text] [Related]
16. Hypervolemic hemodilution: a new approach to subarachnoid hemorrhage.
Stewart-Amidei C
Heart Lung; 1989 Nov; 18(6):590-8. PubMed ID: 2684918
[TBL] [Abstract][Full Text] [Related]
17. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-operative cerebral blood flow changes in subarachnoid haemorrhage.
Mountz JM; McGillicuddy JE; Wilson MW; Bartold SP; Siegal EM
Acta Neurochir (Wien); 1991; 109(1-2):30-3. PubMed ID: 2068964
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
20. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.
Sen J; Belli A; Albon H; Morgan L; Petzold A; Kitchen N
Lancet Neurol; 2003 Oct; 2(10):614-21. PubMed ID: 14505583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
